Colloidal Oatmeal

1. INCI & CAS

INCI: Avena Sativa Kernel Extract · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Avena sativa kernel extract is a cosmetic oat fraction. Beta-glucan content is supplier-specific. Do not claim a drug eczema treatment.

3. Typical use levels (formulation guide)

• The formulation record indicates 0.5–2% for lotions and creams for the formula.

Add in cool-down.

4. Regulatory sources & global compliance

• CosIng provides reference information for Avena Sativa Kernel Extract; confirm the specific grade and intended use against market requirements.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires a safety evaluation of the product containing Avena Sativa Kernel Extract as it will be marketed as part of the finished cosmetic's safety documentation.
• Verify the purchased Avena Sativa Kernel Extract grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; no drug approval or OTC-monograph status follows from this guide and the finished formula still needs patch and stability testing.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; if the formula is oxidation-sensitive, an airless or pump format may be considered; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Avena Sativa Kernel Extract centers on oat comfort.

• The ingredient record does not support drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The available details for Avena Sativa Kernel Extract does not confirm skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Bisabolol · CAS: 23089-26-1

2. Role in the formula

Bisabolol is a monocyclic sesquiterpene alcohol used at low levels in leave-on cosmetics. Prefer the grade named on the supplier TDS.

3. Typical use levels (formulation guide)

• For leave-on, use 0.1–0.5% as a formulation guide.

Incorporate Bisabolol in the oil phase.

4. Regulatory sources & global compliance

• CosIng information about Bisabolol does not itself authorize a particular grade or finished cosmetic.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a product-level safety assessment for the complete formula that contains Bisabolol for the complete formula intended for sale.
• Verify the purchased Bisabolol grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it should not be read as a drug authorization or OTC listing and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Keep the bulk container closed and shaded in a cool area; match the pack choice to the system's oxidation risk; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• This guide frames Bisabolol's cosmetic direction around bisabolol comfort.

• This product entry does not support medical outcomes, cure language, or a product certification not supported by the available facts.
• The documented facts for Bisabolol is not evidence for skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Glycerin serves as the polyol humectant in these cosmetic formats, while the stated percentage remains a formulation reference.

3. Typical use levels (formulation guide)

• 3–8% is listed for gels and serums for the formula.
• 2–5% is listed for creams in this reference.
• The formulation record indicates 2–4% for rinse-off in this reference.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Regulatory sources & global compliance

• The CosIng record for Glycerin, where listed, is informational rather than product-specific authorization.
• The finished-product provisions of Regulation (EC) No 1223/2009 require the completed product containing Glycerin to receive its own safety assessment in the final product context.
• Establish grade-specific details for Glycerin from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; the listed level does not itself confer drug or OTC status and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; select packaging with the formula's oxidation sensitivity in mind; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Glycerin centers on humectant function.

• The development record is not evidence of claims of drug activity, a clinical cure, or an undocumented product certification.
• The ingredient record for Glycerin does not support skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.